National and Kapodistrian University of Athens
Νευροχημικές παράμετροι σε σχέση με στοιχεία της σεξουαλικής συμπεριφοράς επιμύων
Abstract
dc:descriptionSildenafil is the first effective oral treatment for male erectile dysfunction. Although it is generally accepted that its action is peripheral, it has been suggested that it also influences central neural pathways that are involved in male sexual arousal. Recently, it was shown that local sildenafil administration enhances extracellular dopamine in the nucleus accumbens (NAcc) of male rats. The aim of this study was to determine whether sildenafil administration in rats alters dopaminergic, serotonergic and glutamatergic activity in the NAcc and the medial preoptic area (mPOA) during a model of sexual arousal.An acute (2 days) or chronic (21 days) sildenafil regimen (1 mg/kg, intraperitoneally) was administered to male Wistar rats. Thirty minutes after the last sildenafil injection, all males were exposed to noncontact erection sessions by the presentation of inaccessible estrous females. Half of the males had previous experience of noncontact sexual encounter and the other half were exposed for the first time. An equal number of male rats underwent the same experimental procedures under acute or chronic vehicle treatment and served as controls. Tissue levels of dopamine (DA) and its metabolites, 3,4-Dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), serotonin (5-HT) and its metabolite 5-Hydroxyindoleacetic acid (5-HIAA) as well as glutamate, were measured in the mPOA and NAcc with high-performance liquid chromatography with electrochemical detector. Dopamine [(DOPAC+HVA)/ DA] and serotonin (5-HIAA/5-HT) turnovers were also calculated as indices of dopaminergic and serotonergic neurotransmission. The number of the displayed noncontact erections was also recorded.Statistical analysis showed that the percentage of male rats that displayed noncontact erections was significantly higher under sildenafil treatment. In nontrained males, acute and chronic sildenafil treatment increased dopamine and serotonin turnover rates in the mPOA and NAcc. In trained males, acute sildenafil also increased dopamine and serotonin turnover rates in both structures, whereas chronic treatment enhanced serotonin turnover rate only in the mPOA and dopamine turnover rate only in the NAcc. Tissue levels of glutamate were significantly higher in the NAcc of male rats treated acutely or chronically with sildenafil, compared to vehicle-treated males. In the mPOA, glutamate levels were lower in nontrained rats that received sildenafil, but higher in trained rats that had chronic sildenafil treatment, compared to those that had chronic vehicle treatment.Our data confirm that sildenafil, during male sexual arousal, enhances dopaminergic activity in the NAcc, extend these findings to the mPOA and furthermore, reveal sildenafil-induced effects on serotonergic and glutamatergic activity in these brain structures as well. The present findings support an effect of sildenafil on central neural pathways that are involved in the control of sexual arousal.Differences to the observed neurochemical changes between males with and without previous sexual experience, show that the sexual profile and previous experience of the male is an additional factor that could modify the central action of sildenafil.Overall, it can be assumed that sildenafil’s mechanism of action involves not only penile erection as a neurovascular event within the corpus cavernosum, but also the central neurochemical substrate of sexual arousal and motivational aspects of sexual behavior. These neurochemical changes may coordinate somatosensory, psychological, and even social stimuli and thus direct anticipatory and consummatory aspects of sexual behavior.A possible central action of sildenafil in central neuronal systems controlling sexual arousal could explain why PDE5 inhibitors have been so successful in treating patients even with psychogenic erectile dysfunction, and could also be the substrate of the efficacy of PDE5 inhibitors in treating SSRI-induced erectile dysfunction. Furthermore, the finding that certain neurochemical responses seem to be attenuated in sexually experienced males following chronic sildenafil treatment, could imply that the dosing scheme, along with the sexual profile of the male, modifies sildenafil’s central effects.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kyratsas, Christos
- Κυράτσας, Χρήστος
Subjects
dc:subject × 20- Σιλδεναφίλη
- Σεξουαλική διέργεση
- Κεντρικό νευρικό σύστημα και ανασταλείς φωσφοδιεστεράσης
- Μονοαμίνες
- Γλουταμικό οξύ
- Μέση προοπτική περιοχή
- ΕΠΙΚΛΙΝΗΣ ΠΥΡΗΝΑΣ ΔΙΑΦΡΑΓΜΑΤΟΣ
- Επίμυς
- Sexual arousal
- Central nervous system and pres inhibitors
- Monoamines
- Medial preoptic alea
- Nucleus accumbens
- Rat
- Sildenafil
- Glutamate
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38424